These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8809163)

  • 1. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
    Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists.
    Greenspan PD; Fujimoto RA; Marshall PJ; Raychaudhuri A; Lipson KE; Zhou H; Doti RA; Coppa DE; Zhu L; Pelletier R; Uziel-Fusi S; Jackson RH; Chin MH; Kotyuk BL; Fitt JJ
    J Med Chem; 1999 Jan; 42(1):164-72. PubMed ID: 9888841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
    Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
    J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
    McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
    J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of a series of substituted-phenylpropionic acids as a novel class of leukotriene B4 antagonists.
    Konno M; Sakuyama S; Nakae T; Hamanaka N; Miyamoto T; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():411-4. PubMed ID: 1847779
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the characteristics of leukotriene B4 receptor with radio-ligand binding assay].
    Zhao N; Zhu XY; Cheng GF
    Yao Xue Xue Bao; 1996; 31(11):875-7. PubMed ID: 9863260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate.
    Hullot P; Poudrel JM; Muller A; Escale R; Rossi JC; Girard JP; Bonne C
    Arzneimittelforschung; 1997 Jan; 47(1):51-8. PubMed ID: 9037445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the spatial arrangement of the two acid-binding sites on the human neutrophil LTB4 receptor.
    Chaney MO; Froelich LL; Gapinski DM; Mallett BE; Jackson WT
    Receptor; 1992; 2(3):169-79. PubMed ID: 1335328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA cloning and characterization of guinea-pig leukotriene B4 receptor.
    Masuda K; Yokomizo T; Izumi T; Shimizu T
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):79-85. PubMed ID: 10432303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis.
    Junek R; Brůnová B; Kverka M; Panajotová V; Jandera A; Kuchar M
    Eur J Med Chem; 2007 Aug; 42(8):1084-94. PubMed ID: 17448575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residues from transmembrane helices 3 and 5 participate in leukotriene B4 binding to BLT1.
    Sabirsh A; Bywater RP; Bristulf J; Owman C; Haeggström JZ
    Biochemistry; 2006 May; 45(18):5733-44. PubMed ID: 16669617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.
    Goodnow RA; Hicks A; Sidduri A; Kowalczyk A; Dominique R; Qiao Q; Lou JP; Gillespie P; Fotouhi N; Tilley J; Cohen N; Choudhry S; Cavallo G; Tannu SA; Ventre JD; Lavelle D; Tare NS; Oh H; Lamb M; Kurylko G; Hamid R; Wright MB; Pamidimukkala A; Egan T; Gubler U; Hoffman AF; Wei X; Li YL; O'Neil J; Marcano R; Pozzani K; Molinaro T; Santiago J; Singer L; Hargaden M; Moore D; Catala AR; Chao LC; Hermann G; Venkat R; Mancebo H; Renzetti LM
    J Med Chem; 2010 May; 53(9):3502-16. PubMed ID: 20380377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.